Feb 16, 2023
Dr. Rakesh Suri, President and Chief Medical Officer at Fountain Life, reflects on the impact COVID has had on our understanding that, as a society, we are only as safe as the least protected member in our global community. He emphasizes the need to diagnose pre-symptomatic and symptomatic conditions and the long-term...
Feb 16, 2023
Dr. Rakesh Suri, President and Chief Medical Officer at Fountain Life, reflects on the impact COVID has had on our understanding that, as a society, we are only as safe as the least protected member in our global community. He emphasizes the need to diagnose pre-symptomatic and symptomatic conditions and the long-term...
Jan 31, 2023
Tuvik Beker, CEO of Pangea Biomed, is looking for more accurate biomarkers for oncology to determine better who might benefit from a specific drug. Their ENLIGHT platform is a pan-cancer, pan-treatment response predictor and can be used to find the best patient populations to give a new drug. They are also working with...
Jan 31, 2023
Tuvik Beker CEO of Pangea Biomed is looking for more accurate biomarkers for oncology to better determine who might benefit from a specific drug. Their ENLIGHT platform is a pan-cancer, pan-treatment response predictor and can be used to find the best patient populations to give a new drug. They are also working with...
Jan 23, 2023
Mehdi Maghsoodnia is the CEO of 1health and is determined to bring advanced diagnostic medical tests to a broader audience to enable more patients to benefit from precision medicine advancements. Too often, patients are put on costly drugs that are not effective. Using data from advanced testing allows clinicians to...